Back to BlackRock, Inc. BlackRock, Inc.

TNXPTNXP
6 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in TONIX PHARMACEUTICALS HLDG C

Yes. BlackRock holds 1,398,041 shares of TNXP (Tonix Pharmaceuticals), worth $17.8M, as of its Q2 2026 13F filing. It increased the position by 429,864 shares (+44.4%) from Q1 2026. BlackRock has held TNXP since Q1 2025, across 6 quarterly 13F filings.

Current Value

$17.8M

Current Shares

1.4M

Total Value Change

+$16.6M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+44.4%
$17.8M0.0%$12.76
38
2026-Q1
Increased
968,177
+9.4%
$13.3M0.0%$13.75
31
2025-Q4
Increased
884,881
+29.8%
$13.8M0.0%$15.62
35
2025-Q3
Increased
681,530
+62.1%
$16.5M0.0%$24.16
41
2025-Q2
Increased
420,448
+504.3%
$15.1M0.0%$35.98
45
2025-Q1
New
69,580
-
$1.2M0.0%$17.88
39

Other major holders of TNXP: Point72 Asset Management, L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used